Joint Strategic Needs Assessments (JSNAs) are assessments of the current and future health and social care needs of the local community (Department of Health, 2013).
They aim to highlight needs and assets around topics of joint strategic importance, providing recommendations for action to improve health and wellbeing and reduce health inequalities.
Health and Wellbeing Boards have a statutory duty to produce JSNAs, and they should be used to inform the Joint Health and Wellbeing Strategy.
Government legislation makes production of the JSNA mandatory for local authorities and Clinical Commissioning Groups through the Health and Wellbeing Board.
The responsibility to produce the JSNA is given to the Health and Wellbeing Board. The Board then uses the JSNA to agree priorities in order to develop the Health & Wellbeing Strategy. The Strategy will, in turn, help to shape local health and social care commissioning plans.
Pharmaceutical Needs Assessment (PNA) compliments the Joint Strategic Needs Assessment (JSNA) because it enables the Health and Wellbeing board and stakeholders to understand the pharmaceutical needs of our local population and use this information to develop pharmaceutical services to meet identified unmet needs. The Health and Wellbeing Board is responsible for the delivery of the PNA.
The JSNA undergoes a programme of continuous improvement including future national guidance, local priorities and feedback from consultation and engagement with key stakeholders.